A detailed history of Founders Financial Securities LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Founders Financial Securities LLC holds 11,907 shares of BMY stock, worth $700,965. This represents 0.06% of its overall portfolio holdings.

Number of Shares
11,907
Previous 13,612 12.53%
Holding current value
$700,965
Previous $565,000 9.03%
% of portfolio
0.06%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $67,620 - $88,233
-1,705 Reduced 12.53%
11,907 $616,000
Q2 2024

Aug 02, 2024

BUY
$40.25 - $52.99 $48,783 - $64,223
1,212 Added 9.77%
13,612 $565,000
Q1 2024

Apr 17, 2024

BUY
$47.98 - $54.4 $594,952 - $674,560
12,400 New
12,400 $672,000
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $27,777 - $30,842
436 Added 2.2%
20,228 $1.29 Million
Q1 2023

May 04, 2023

BUY
$65.71 - $74.53 $53,487 - $60,667
814 Added 4.29%
19,792 $1.37 Million
Q4 2022

Feb 08, 2023

SELL
$68.48 - $81.09 $61,563 - $72,899
-899 Reduced 4.52%
18,978 $1.37 Million
Q3 2022

Oct 27, 2022

BUY
$0.13 - $76.84 $52 - $31,273
407 Added 2.09%
19,877 $1.41 Million
Q2 2022

Jul 27, 2022

BUY
$72.62 - $79.98 $27,813 - $30,632
383 Added 2.01%
19,470 $1.5 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $43,036 - $51,604
700 Added 3.81%
19,087 $1.39 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $31,319 - $36,511
584 Added 3.28%
18,387 $1.15 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $51,892 - $60,784
877 Added 5.18%
17,803 $1.05 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $79,678 - $86,769
1,287 Added 8.23%
16,926 $1.13 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $43,970 - $49,454
741 Added 4.97%
15,639 $987,000
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $860,210 - $974,776
14,898 New
14,898 $924,000
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $923,187 - $1.02 Million
-16,075 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $17,597 - $20,572
321 Added 2.04%
16,075 $945,000
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $249,956 - $363,245
-5,387 Reduced 25.48%
15,754 $878,000
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $6,052 - $7,895
123 Added 0.59%
21,141 $1.36 Million
Q3 2019

Oct 17, 2019

BUY
$42.77 - $50.71 $60,134 - $71,298
1,406 Added 7.17%
21,018 $1.07 Million
Q2 2019

Jul 22, 2019

BUY
$44.62 - $49.34 $875,087 - $967,656
19,612 New
19,612 $889,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Founders Financial Securities LLC Portfolio

Follow Founders Financial Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Founders Financial Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Founders Financial Securities LLC with notifications on news.